medigraphic.com

2006, Number 4

<< Back Next >>

Anales de Radiología México 2006; 5 (4)

Ethanol and Lipidol injection through percutaneous transthoracic boarding in rats liver, guided by Helical Computerized Tomography

Dena EEJ, Rodriguez NP, Hernández GM, Cervantes GC, Jiménez GJ, Olvera NR, Rojero VJ, Campos GRC, Ramos SO, Fuentes GM, Arriaga CH

Language: Spanish
References: 38
Page: 305-312
PDF size: 174.11 Kb.


ABSTRACT

Objective: Assay a new access via in the liver of 25 rats through transthoraxic percutaneous approach, inject ethanol and Lipidol with a fine needle, using as guide the helicoidal computerized (HTAC) tomography and to its usefulness in patients with subdiaphragmatic liver trauma or where the transcatheter percutaneous access is difficult for carrying out procedures emboligenous.
Materials and method: All the procedures were carried out in accordance with Committee of Ethics of the General Hospital of Mexico, of the Secretary of Health and of research and experimentation in animals according to the Law of Animal Protection and International Standards of animals care and protection. A Protocol of Experimental Research was carried out, where: HTAC as a guide for the introduction of a needle through transthoraxic percutaneous approach, through the right lung bottom portion until reaching the subphrenic region of the liver. Ethanol and Lipidol are injected; an immediate control was carried out, a new tracking after 24 hours later and one week later, to verify the integrity of the lung base and revision again through pathology of the organs.
Results: Complications neither deceases were observed during the procedure. The deposit of Lipidol allows the immediate visualization of the place in which it was injected favoring follow-up to the day and the week after the procedure.
Conclusions: This transthoraxic puncture technique is a novel method, it is considered reliable and it is an alternative in human patients with subdiaphragmatic liver trauma or where the percutaneous transcatheter access makes difficult to carry out emboligenous procedures.


REFERENCES

  1. Mc Glynn KA, El-Serag HB. Global epidemiology of hepatocellular carcinoma. En: Bruix J. Hepatocellular carcinoma. Permaneyer Publications 2004 p.1-23.

  2. Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A,Schmitt J, et al. Transarterial chemoembolization for hepatocellular carcinoma: Volumetric and morphologic CT criteria for assessement of prognosis and therapeutic success, results from a liver transplantation center. Radiology 2000; 21: 349-57.

  3. Shiina S, Tagawa K, Unuma T, et al. Percutaneus ethanol injection therapy for the hepatocellular carcinoma; analysis of 77 patients. AJR J Roengenol 1990; 155: 1221-6.

  4. Livraghi T, Bolondi L, Lazzaroni S, et al.Percutaneus ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis; a study on 207 patiens. Cancer 1992; 69: 925-9.

  5. Sugiura N, Takara K, Ohto M, et al. Percutaneus intratumoral injection of ethanol under ultrasound imaging for treatment of small hepatocellular carcinoma. Acta Hepatol Jpn 1983; 24: 920.

  6. Shinagawa T, Ukaji H, Lino Y, et al. Intratumoral injection of absolute ethanol under ultrasound imaging for treatment of samll hepatocellular carcinoma: attempts in three cases. Acta Hepatol Jpn 1985; 26: 99-105.

  7. Joseph FB, Baumgarten DA, Bernardino ME. Hepatocellular carcinoma: CT Appearance after percutaneus ethanol ablation therapy. Radiology 1993; 186: 553-6.

  8. Tomoda K, Hori S, Nakamura H, Hashimosto T, Murakami T, Ishida T, et al. Transthoracic percutaneus ethanol injection into the liver. Invest Radiol 1994; 29: 839-41.

  9. Lencioni R, Vignali C, Caramella D, Cioni R, Mazzeo S, Bartolozzi C. Transcatheter arterial embolization followed by percutaneus ethanol injection in the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 1994; 17: 70-5.

  10. Koda M, Okamoto K, Miyoshi Y, Kato S, Murawaki Y, Horie Y, et al. Combination therapy with transcatheter arterial embolization and percutaneus ethanol injection for advanced hepatocellular carcinoma. Hepatogastroenterology 1994; 41: 25-9.

  11. Tateshi H, Kinuta M, Furukawa J, Takata N, Muruyama H, Oi H,et al. Follow up study combination treatment (TAE and PEIT) for unresectable hepatocellular carcinoma. Cancer Chemoter Pharmacol 1994; 33: S119-S123.

  12. Kato T, Saito Y, Niwa M, Ishiguro J, Ogoshi K. Combination therapy of transcatheter chemoembolization and percutaneus ethanol injection therapy for unresectable hepatocellular cacinoma. Cancer Chemoter Pharmacol 1994; 33: S115-118.

  13. Horiguchi Y, Sekoguchi B, Imai H, Suzuki T, Kubo H, Itoh H, et al. Treatment of choice for unresectable small liver cancer: percutaneus ethanol injection therapy or transarterial chemoembolization therapy. Cancer Chemother Pharmacol 1994; 33: S111-S114.

  14. Onodera H, Ukai K, Nakano N, Takeda T, Suzuki H, Okata T, et al. Outcomes of 116 patients with hepatocellular carcinoma. Cancer Chemoter Pharmacol 1994; 33: S103-S108.

  15. Bolan GW, Lee MJ, Dawson SL, Mueller PR. Percutaneus injection of ethanol in a patient with a solitary hepacellular carcinoma. AJR 1993; 161: 1071-7.

  16. Livraghi T, Lazzaroni S, Pellicano S, Ravasi S, Torzilli G, Vettori C. Percutaneus ethanol injection of hepatic tumors: Single-Session therapy with general anesthesia. AJR 1993; 161: 1065-9.

  17. Amin Z, Lees WR, Bown SG. Hepatocellular carcinoma: CT appearence after percutaneus ethanol ablation therapy. Radiology 1993; 188: 882-3.

  18. Shiina S, Tagawa K, Unuma T, Fujino H, Uta Y, Niwa Y, et al. Pecutaneus ethanol injection therapy of hepatocellular carcinoma: Analysis of 77 patients. AJR 1990; 155: 1221-6.

  19. Livraghi T, Salmi A, Bolondi L, Marin G, Arienti V, Monti F, et al. Small hepatocellular carcinoma: Percutaneus alcohol injection-results in 23 patients. Radiology 1988; 168: 313-17.

  20. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio Y, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneus ethanol injection. Radiology 1995; 197: 101-8.

  21. Shiina S, Tagawa K, Unuma T, Fujino H, Uta Y, Hata Y, Niwa Y, Shiratori Y, Terano A, Sugimoto T. Pecutaneus ethanol injection therapy for neoplasms located on the surface of the liver. AJR 1990; 155: 507-9.

  22. Sironi S, Livraghi T, Angeli E, Vanzulli A, Villa G, Colombo E, Taccagni G, Del Maschio A. Small hepatocellular carcinoma: MR follow-up of treatment with percutaneus ethanol injection. Radiology 1993; 187: 119-123.

  23. Joseph FB, Baumgarten DA, Bernardino ME. Hepatocellular carcinoma: CT appearance after percutaneus ethanol ablation therapy. Radiology 1993; 186: 553-6.

  24. Honda N, Guo Q, Uchida H, Ohishi H, Hiasa Y. Percutaneus hot saline injection theraphy for hepatic tumors: An alternative to percutaneus ethanol injection therapy. Radiology 1994; 190: 53-7.

  25. Nakao N, Uchida H, Kamino K, Nishimura Y, Ohishi H, Takayasu Y, Miura K. Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on restrospective multivariate analysis. Cardiovasc Intervent Radiol 1994; 17: 76-80.

  26. Bronowicki JP,Vetter D,Dumas F,Boudjema K,Bader R,Weiss AM,Wenger JJ,Boissel P, Bigard MA,Doffoel M. Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4 year study of 127 French patients. Cancer 1994; 74: 16-24.

  27. Mondazzi L, BotteliR, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Albert A, Ideo G. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma a multivariate analysis of prognostic factors. Hepatology 1994; 19: 1115-23.

  28. Watanabe S,Nishioka M,Ohta Y, Ogawa N, Ito S, Yamamoto Y. Prospective and randomized controlled study of chemoem-bolization therapy in patients with advanced heaptocellular carcinoma. Cooperative study group for liver cancer treatment in Shikoku area. Cancer Chemother Pharmacol 1994; 33: 593-6.

  29. Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Hirohashi S, Nishimura Y, Guo O, Ohishi H, Nagano N, Yoshioka T, et al. Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: Follow up CT and therapeutic results. Cancer Chemother Pharmacol 1994; 33: S60-S68.

  30. Yamada T, Makita F, Takehara K, Saitou S, Satou K, Endou K, Shimoda R, Matsuzaki Y, Matsumoto T, Yuasa K, et al. Evaluation of the therapeutic effect of TAE on primary liver cancer. Cancer Chemother Pharmacol 1994; 33: S55-S59.

  31. Tarazov PG. Iodized oil in the portal vein after arterial chemoembolization of liver metastases a caution regarding hepatic necrosis. Acta Radiol 1994; 35: 143-6.

  32. Nakamura H, Mitani T, Murakami T, Hasimoto T, Tsuda K, Nakanishi K, Ishida T, Tomoda K, Hori S, Kozuka T, et al. Five year survival after transcatheter chemoembolization for hepatocellular carcinoma. Cancer Chemoter Pharmacol 1994; 33: S89-S92.

  33. Oi H, Kim T, Kishimoto H, Matsushita M, Tateishi H, Okamura J. Effective cases oftranscatheter arterioprtal chmeoembolization with high dose iodized oil for hepatocellular carcinoma. Cancer Chemoter Pharmacol 1994; 33: S69-S73.

  34. Shiono T, Yoshihawa K, Hisamatsu K, Takenaka E. Efficacy of emulsion containing Gd-DTPA and lipiodol in hepatic transcatheter arterial embolization. Radiat Med 1993; 11: 187-90.

  35. Clouse ME, Stokes KR, Kruskal JB, Perry LJ, Stuart KE, Nasser IA. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin ethiodized oil emulsion and gelatin sponge powder. J Vasc Interv Radiol 1993; 4: 717-25.

  36. Yamashita Y, Torashima M, Ougni T, Yammaoto A, Harada M, Miyazaki T, Takanashi M. Liver paranchymal changes after transcatheter arterial embolization therapy for hepatoma; CT evaluation. Abdom Imaging 1993; 18: 352-6.

  37. Akashi Y, Koreeda CH, Mizuno T, Inoue K, Kawa SKH, Tanaka Y. Hepatic parenchymal changes after the intraarterial injection of lipiodol in tumor bearing rabbits. Invest Radiol 1993; 28: 128-32.

  38. Struk D, Rankin RN, Karlik SJ. Stability studies on chemoembolization mixtures. Invest Radio 1993; 28: 1024-7.




2020     |     www.medigraphic.com